Back

Prevalence of high inflammatory risk across heart failure subtypes in Europe: a sub-analysis of the global POSEIDON study

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Heart failure risk: from inflammation to prediction Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Jochen Muller-Ehmsen

Bremen (Germany)

6 More presentations in this session

Presentation thumbnail
Sex differences in cardiovascular inflammation defined by high-sensitivity C-reactive protein across heart failure phenotypes: insights from POSEIDON
Professor S. Stoerk (Wuerzburg, DE)
Abstract
Presentation thumbnail
From desalination to deficiency: shifting magnesium-related mortality in heart failure patients
Doctor K. Faierstein (Ramat Gan, IL)
Abstract
Presentation thumbnail
Does evidence-based treatment recommendations implementation improve 1-year outcomes in patients with heart failure?
Doctor M. Anguita Gamez (Madrid, ES)
Abstract
Presentation thumbnail
Risk of major adverse cardiovascular events after RSV-related hospitalization among US adults with heart failure
Doctor D. Bhatt (New York City, US)
Abstract
Presentation thumbnail
Sex differences in cardiorenometabolic syndrome across heart failure: prognostic impact in a low-middle income country
Doctor A. Jordan (Mexico City, MX)
Abstract

Access the full session

Session thumbnail
Heart failure risk: from inflammation to prediction

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
POSEIDON: prevalence of high inflammatory risk in heart failure across the ejection fraction spectrum
10 May 2026
thumbnail
Congress Presentation
The real-life prevalence and risk factors of elevated CRP in patients from cardiology outpatient clinics. The results from the STAR-Lp(a) study.
1 September 2025
thumbnail
Congress Presentation
Heart failure incidence and prevalence from 2014-2018: a nationwide registry study
29 June 2021
thumbnail
Congress Presentation
Coagulation cascade, inflammatory and fibrosis markers in patients with preserved ejection fraction heart failure and AF
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources